Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2023 Jun 29;14:1233632. doi: 10.3389/fimmu.2023.1233632

Corrigendum: Patients’ IgLON5 autoantibodies interfere with IgLON5–protein interactions

Jon Landa 1, Ana Beatriz Serafim 1, Carles Gaig 2, Albert Saiz 2, Inga Koneczny 3,4, Romana Hoftberger 3,4, Joan Santamaria 2, Josep Dalmau 1,2,5,6, Francesc Graus 1, Lidia Sabater 1,*
PMCID: PMC10349639  PMID: 37457724

In the published article, there was an error in the Funding statement. We did not include that Ana Beatriz Serafim is a recipient of a Doctoral Fellowship grant from Fundação para a Ciência e Tecnologia (FCT) contract number 2022.13121.BD and should be acknowledged. The correct Funding statement appears below.

Funding Statement

This study has been funded by Instituto de Salud Carlos III through the project FIS21/00165 LS, CG (co-funded by the European Regional Development Fund “Investing in your future”). We thank the European Joint Programme on Rare Diseases (EJPRD) for funding a Networking event (contract number 463001015) on IgLON5 disease LS, CG, FG, JD from the European Union’s Horizon 2020 research and innovation programme under the EJP RD COFUND-EJP N°825575. IDIBAPS belongs to CERCA (Centres de recerca de Calalunya). IK was funded by a Hertha Firnberg project grant by the Austrian Science Fund (FWF) (Grant No. T996-B30). RH was supported by grants from the Austrian Science Fund FWF: project I4685-B (SYNABS), and DOC 33-B27. The proteomics analyses were performed in the CRG/UPF Proteomics Unit which is part of the Proteored, PRB3 and is supported by grant PT17/0019, of the PE I+D+i 2013-2016, funded by ISCIII and ERDF. ABS thanks Fundação para a Ciência e Tecnologia (FCT) of Portugal for the doctoral fellowship grant number 2022.13121.BD.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES